Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-05 Sale | 2023-04-07 9:02 pm | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $108.42 | $1,084,200 | 102,851 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 9:33 pm | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $122.13 | $1,221,300 | 112,851 (Direct) | View |
| 2023-02-15 Sale | 2023-02-17 9:34 pm | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $119.38 | $596,900 | 122,851 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 8:42 pm | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $119 | $595,000 | 127,851 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2030-08-11 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 605,506 | $0 | 0 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 7:03 pm | N/A 2030-08-11 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 78,162 | $0 | 140,811 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 7:03 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 78,162 | $3.1 | 140,811 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 9:02 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $3.7 | 102,851 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 9:02 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $0 | 102,851 (Direct) | View |
| 2023-03-06 Exercise | 2023-03-08 9:33 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $3.7 | 112,851 (Direct) | View |
| 2023-03-06 Exercise | 2023-03-08 9:33 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $0 | 112,851 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 9:34 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $3.7 | 122,851 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 9:34 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $0 | 122,851 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 8:42 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $3.7 | 127,851 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 8:42 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $0 | 127,851 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 8:19 pm | N/A 2032-12-15 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 12,920 | $0 | 12,920 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 8:35 pm | N/A 2032-12-08 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 43,896 | $0 | 43,896 (Direct) | View |
| 2022-05-20 Option Award | 2022-05-20 7:13 pm | 2025-05-20 2032-05-19 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 86,582 | $0 | 86,582 (Direct) | View |
| 2021-11-14 Option Award | 2021-11-16 9:08 pm | N/A 2031-11-13 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 102,155 | $0 | 102,155 (Direct) | View |
Ownership | 2021-03-11 9:24 pm | N/A 2030-08-11 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 0 | $0 | 389,953 (Direct) | View |
| 2020-05-22 Exercise | 2020-05-27 06:09 am | N/A N/A | Histogen Inc. | HSTO | Marshall Keith W EVP, COO & CFO | 38,500 | $0 | 19,885 (Direct) | View |
| 2020-05-22 Tax Withholding | 2020-05-27 06:09 am | N/A N/A | Histogen Inc. | HSTO | Marshall Keith W EVP, COO & CFO | 18,615 | $0.56 | 19,885 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:12 pm | N/A 2027-08-30 | Conatus Pharmaceuticals Inc. | CNAT | Marshall Keith W EVP, COO & CFO | 770,000 | $0 | 385,000 (Direct) | View |
| 2019-08-01 Option Award | 2019-08-01 4:12 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | Marshall Keith W EVP, COO & CFO | 385,000 | $0 | 385,000 (Direct) | View |